AR013949A1 - Utilizacion de inhibidores del intercambiador entre sodio e hidrogeno para la preparacion de un medicamento destinado al tratamiento de enfermedades que son provocadas por protozoos - Google Patents
Utilizacion de inhibidores del intercambiador entre sodio e hidrogeno para la preparacion de un medicamento destinado al tratamiento de enfermedades que son provocadas por protozoosInfo
- Publication number
- AR013949A1 AR013949A1 ARP980104256A ARP980104256A AR013949A1 AR 013949 A1 AR013949 A1 AR 013949A1 AR P980104256 A ARP980104256 A AR P980104256A AR P980104256 A ARP980104256 A AR P980104256A AR 013949 A1 AR013949 A1 AR 013949A1
- Authority
- AR
- Argentina
- Prior art keywords
- preparation
- treatment
- bovine
- pathogenic
- inhibitors
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Tropical Medicine & Parasitology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pyrrole Compounds (AREA)
- Indole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Los inhibidores del intercambiador de sodio e hidrogeno se adecuan a solas o en combinacion con otras clases de sustancias activas para la preparacion deun medicamento destinado al tratamiento de enfermedades que son provocadas por protozoos patogenos en veterinaria y en seres humanos, tal como por parásitosactivos intracelularmente de las clases de parásitos activos intracelularmente de las clases Apicom]lexa y Zoomastigophora, especialmente Tripanosomas,Plasmodios (patogenos de malaria), Leishmanias, Babesias y Theilerías, Criptosporididas, Sarcocístidas, amebas, Coccidios y Tricomonas. De modoespecialmente preferido los inhibidores del IHE se adecuan para la preparacion de un medicamento destinado al tratamiento de la malaria tropical, de lamalaria terciana, de la malaria cuartana, de la toxoplasmosis, de la coccidiosis, de la sarcoporidosis intestinal, de la criptosporidosis, de laenfermedad de Chagas y de las formas cutáneas y viscerales así como otros tipos deleishmaniosis, así como para la preparacion de un medicamento destinado al tratamiento de animales, que habían sido afectados por protozoos patogenos enveterinaria, tal como son provocados por Theileria parva, el agente patogeno de la fiebrede la Costa Oriental de reses de bobino, Babesia begemina, el agentepatogeno de la fiebre de Texas en reses de bovino y bufalos, Babesia bovis, el agente patogeno de la babesiosis bovina europea, así como babesiosis en perros,gatos y corderos, Sarcocystidae, los agentes patogenos de sarcocistosis en animales ovinos, bovinos y porcinos, Cryptosporidiidae, los agentes patogenosde criptosporidosis en animales bovinos y aves, Coccidios, los agentes patogenos de animales cunidos, bovinos, ovinos, caprinos y porcinos, pero
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19737463A DE19737463A1 (de) | 1997-08-28 | 1997-08-28 | Verwendung von Inhibitoren des Natrium-Wasserstoff-Austauschers zur Herstellung eines Arzneimittels zur Behandlung von Erkrankungen, die durch Protozoen verursacht werden |
Publications (1)
Publication Number | Publication Date |
---|---|
AR013949A1 true AR013949A1 (es) | 2001-01-31 |
Family
ID=7840411
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP980104256A AR013949A1 (es) | 1997-08-28 | 1998-08-26 | Utilizacion de inhibidores del intercambiador entre sodio e hidrogeno para la preparacion de un medicamento destinado al tratamiento de enfermedades que son provocadas por protozoos |
Country Status (26)
Country | Link |
---|---|
US (1) | US6114393A (es) |
EP (1) | EP0901788A3 (es) |
JP (1) | JPH11171792A (es) |
KR (1) | KR100567144B1 (es) |
CN (1) | CN1244322C (es) |
AR (1) | AR013949A1 (es) |
AU (1) | AU738599B2 (es) |
BR (1) | BR9803243A (es) |
CA (1) | CA2246407A1 (es) |
CZ (1) | CZ296815B6 (es) |
DE (1) | DE19737463A1 (es) |
HK (1) | HK1018589A1 (es) |
HR (1) | HRP980468A2 (es) |
HU (1) | HU225583B1 (es) |
ID (1) | ID20794A (es) |
IL (1) | IL125946A0 (es) |
MY (1) | MY137406A (es) |
NO (1) | NO320368B1 (es) |
NZ (1) | NZ331566A (es) |
PL (1) | PL191267B1 (es) |
RU (1) | RU2225726C2 (es) |
SG (1) | SG74074A1 (es) |
SK (1) | SK285457B6 (es) |
TR (1) | TR199801669A2 (es) |
TW (1) | TW592690B (es) |
ZA (1) | ZA987781B (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9224739D0 (en) * | 1992-11-26 | 1993-01-13 | Wellcome Found | Medicaments |
CA2395333C (en) * | 1999-12-23 | 2009-01-13 | Pfizer Products Inc. | Hydrogel-driven drug dosage form |
US7375138B2 (en) | 2002-05-18 | 2008-05-20 | Sanofi-Aventis Deutschland Gmbh | Pentafluorosulfanylbenzoylguanidines, processes for their preparation, their use as medicaments or diagnostic aids, and medicaments comprising them |
FR2840302B1 (fr) * | 2002-06-03 | 2004-07-16 | Aventis Pharma Sa | Derives d'isoindolones, procede de preparation et intermediaire de ce procede a titre de medicaments et compositions pharmaceutiques les renfermant |
US6878748B2 (en) | 2002-06-13 | 2005-04-12 | Aventis Pharma Deutschland Gmbh | Fluorinated cycloalkyl-derivatized benzoylguanidines, process for their preparation, their uses as medicament, and medicament containing them |
LT3649109T (lt) * | 2017-07-04 | 2021-09-27 | Sanofi | Etinilo junginiai, jų gamyba ir jų terapinis panaudojimas maliarijos gydymui |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1336871A (en) * | 1970-01-02 | 1973-11-14 | Wellcome Found | Method for preparing biologically active substituted amidines |
US4088780A (en) * | 1974-05-15 | 1978-05-09 | Bayer Aktiengesellschaft | Substituted phenylguanidines and processes for their preparation and use |
US4032655A (en) * | 1974-05-15 | 1977-06-28 | Bayer Aktiengesellschaft | Phenylguanidines useful as anthelmintic agents |
US4544670A (en) * | 1982-08-24 | 1985-10-01 | William H. Rorer, Inc. | Method of treating coccidiosis with acyl guanidines |
DE3929582A1 (de) * | 1989-09-06 | 1991-03-07 | Hoechst Ag | Benzoylguanidine, verfahren zu ihrer herstellung, ihre verwendung als medikament sowie sie enthaltendes medikament |
IN172842B (es) * | 1990-05-17 | 1993-12-11 | Boots Pharmaceuticals Limited | |
US5352667A (en) * | 1991-11-22 | 1994-10-04 | Ofer Lider | Non-peptidic surrogates of the Arg-Gly-Asp sequence and pharmaceutical compositions comprising them |
CZ284456B6 (cs) * | 1992-02-15 | 1998-12-16 | Hoechst Aktiengesellschaft | Aminosubstituované benzoylguanidiny, způsob jejich přípravy, jejich použití jako léčiv a léčivo, které je obsahuje |
GB9224739D0 (en) * | 1992-11-26 | 1993-01-13 | Wellcome Found | Medicaments |
DE4318658A1 (de) * | 1993-06-04 | 1994-12-08 | Hoechst Ag | Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
DE4318756A1 (de) * | 1993-06-05 | 1994-12-08 | Hoechst Ag | Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
DE19502644A1 (de) * | 1995-01-28 | 1996-08-01 | Merck Patent Gmbh | 4-Amino-benzoylguanidin-Derivate |
FR2734263B1 (fr) * | 1995-05-17 | 1997-06-20 | Fournier Ind & Sante | Analogues de la 15-deoxyspergualine, leur procede de preparation et leur utilisation en therapeutique |
CA2223910C (en) * | 1995-06-07 | 2008-09-16 | Magainin Pharmaceuticals Inc. | Aminosterol compounds useful as inhibitors of the sodium/proton exchanger (nhe), pharmaceutical methods and compositions employing such inhibitors, and processes for evaluating the nhe-inhibitory efficacy of compounds |
DE19542306A1 (de) * | 1995-11-14 | 1997-05-15 | Hoechst Ag | Sulfonylamino-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
-
1997
- 1997-08-28 DE DE19737463A patent/DE19737463A1/de not_active Withdrawn
-
1998
- 1998-08-24 EP EP98115902A patent/EP0901788A3/de not_active Withdrawn
- 1998-08-26 IL IL12594698A patent/IL125946A0/xx not_active IP Right Cessation
- 1998-08-26 ID IDP981166A patent/ID20794A/id unknown
- 1998-08-26 HU HU9801925A patent/HU225583B1/hu not_active IP Right Cessation
- 1998-08-26 AR ARP980104256A patent/AR013949A1/es unknown
- 1998-08-26 TR TR1998/01669A patent/TR199801669A2/xx unknown
- 1998-08-26 US US09/140,544 patent/US6114393A/en not_active Expired - Fee Related
- 1998-08-26 NZ NZ331566A patent/NZ331566A/en unknown
- 1998-08-26 CA CA002246407A patent/CA2246407A1/en not_active Abandoned
- 1998-08-26 SK SK1174-98A patent/SK285457B6/sk unknown
- 1998-08-26 CZ CZ0272998A patent/CZ296815B6/cs not_active IP Right Cessation
- 1998-08-27 RU RU98116380/15A patent/RU2225726C2/ru not_active IP Right Cessation
- 1998-08-27 CN CNB981184928A patent/CN1244322C/zh not_active Expired - Fee Related
- 1998-08-27 MY MYPI98003946A patent/MY137406A/en unknown
- 1998-08-27 HR HR19737463.8A patent/HRP980468A2/hr not_active Application Discontinuation
- 1998-08-27 NO NO19983943A patent/NO320368B1/no unknown
- 1998-08-27 ZA ZA987781A patent/ZA987781B/xx unknown
- 1998-08-27 KR KR1019980034759A patent/KR100567144B1/ko not_active IP Right Cessation
- 1998-08-27 AU AU81894/98A patent/AU738599B2/en not_active Ceased
- 1998-08-27 SG SG1998003335A patent/SG74074A1/en unknown
- 1998-08-27 JP JP10241376A patent/JPH11171792A/ja not_active Abandoned
- 1998-08-27 BR BR9803243A patent/BR9803243A/pt not_active Application Discontinuation
- 1998-08-28 PL PL328265A patent/PL191267B1/pl not_active IP Right Cessation
- 1998-09-23 TW TW087114024A patent/TW592690B/zh not_active IP Right Cessation
-
1999
- 1999-07-28 HK HK99103255A patent/HK1018589A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2234236T3 (es) | Feromonas calmantes del cerdo para disminuir el estres, la ansiedad y la agresividad. | |
ES2063011T3 (es) | Agentes antibacteriales de quinolonas y naftiridinas que contienen un alfa-aminoacido en la cadena lateral del 7-sustituyente. | |
ES2565190T3 (es) | Reducción de mareos, un efecto secundario asociado a la terapia de pirfenidona | |
Gonzales et al. | Therapeutic and persistent efficacy of doramectin against Boophilus microplus in cattle | |
ECSP056074A (es) | Composiciones y método para tratar las infecciones microbianas y parasitarias en el ganado y otros animales | |
ECSP056189A (es) | Composiciones y método para el tratamiento de infecciones en ganado vacuno y porcino | |
CO5611162A2 (es) | Metodos para prevenir enfermedades reproductivas en el ganado vacuno | |
ES2038122T3 (es) | Un procedimiento para la preparacion de una composicion veterinaria2. | |
AR013949A1 (es) | Utilizacion de inhibidores del intercambiador entre sodio e hidrogeno para la preparacion de un medicamento destinado al tratamiento de enfermedades que son provocadas por protozoos | |
ES2149740T3 (es) | Dispositivo de inseminacion artificial para animales de cria tales como, particularmente, cerdas. | |
AR021690A1 (es) | Empleo de inhibidores del canal de ktq1 para la preparacion de un medicamento para el tratamiento de enfermedades, que son provocadas por helmintos yectoparasitos. | |
AR019579A1 (es) | USO DE UN INICIADOR DE LA RESPUESTA SEXUAL DEL SISTEMA NERVIOSO CENTRAL PARA LA FABRICACIoN DE UNA COMPOSICIoN FARMACÉUTICA PARA LA NORMALIZACIoN DE LA CRONOMETRACIoN DE LA RESPUESTA SEXUAL O PARA LA PROFILAXIS O REDUCCIoN DE LA LESIoN TISULAR GENITAL EN MAMíFEROS | |
McMeekan et al. | Effects of shallow scoop and deep scoop dehorning on plasma cortisol concentrations in calves | |
Prunier et al. | Endocrine and behavioural responses of sows to human interactions and consequences on reproductive performance | |
Hogue et al. | Fertility of ewes bred naturally and artificially after estrous cycle synchronization with an oral progestational agent | |
ES2064669T3 (es) | Raciones que proporcionan resistencia a las enfermedades y aditivo alimentario para ganado vacuno o porcino. | |
PE117199A1 (es) | Formulaciones parasiticidas | |
Olias et al. | The significance of cryptosporidiosis for the health of calves in Switzerland | |
PH27250A (en) | The use of naphthoquinones against toxoplasmosis | |
Holden et al. | Operant‐conditioning programme for White rhinoceros, Black rhinoceros and Indian or Greater one‐horned Asian rhinoceros Ceratotherium simum, Diceros bi cornis and Rhinoceros unicornis at Whipsnade Wild Animal Park, Dunstable, UK | |
Richey | Management of anaplasmosis in beef cattle | |
RU2267269C1 (ru) | Способ стимуляции репродуктивной функции свиноматок | |
Alawa | ANP 506 ANIMAL HEALTH AND DISEASES | |
RU2258498C2 (ru) | Способ стимуляции репродуктивной функции свиноматок | |
BR9712633A (pt) | Método para o tratamento de infecção por streptococcus pneumoniae |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |